Literature DB >> 23008882

Improving patient care--the first year in a dedicated surgical assessment unit.

E Boyle1, H McCormack, A O'Rourke, M Clarke-Moloney, E Kavanagh, P Grace, P Burke.   

Abstract

A surgical assessment unit (SAU) was established in October 2009 at the Mid-Western Regional Hospital. We assessed this servic in its initial year and compared it to Emergency Department (ED) services. We audited SAU and ED databases and theatre logbooks from November 2009 to October 2010. 1949 patients were referred to the SAU and 857 patients were admitted (44%). Only 44 SAU patients (6%) waited more than 6 hours for a bed compared to 828 patients (68%) admitted through the ED. SAU patients who required emergency surgery had a shorter waiting time before theatre (37 (18.6%) vs 9(6%) waited less than 6 hours, p < 0.05). To summarise, we found that almost 2,000 patients who would otherwise have presented to the ED were referred to the SAU. Waiting times for admission and theatre were significantly shorter. Further resource allocation could expand the service and improve it further, by diverting more patients from the ED.

Entities:  

Mesh:

Year:  2012        PMID: 23008882

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  3 in total

1.  The impact of regional reconfiguration on the management of appendicitis.

Authors:  D A Healy; D P McCartan; P A Grace; A Aziz; F Dermody; M Clarke Moloney; J C Coffey; S R Walsh; P E Burke
Journal:  Ir J Med Sci       Date:  2013-10-04       Impact factor: 1.568

2.  Emergency Management of Gallbladder Disease: Are Acute Surgical Units the New Gold Standard?

Authors:  Rose Shakerian; Anita Skandarajah; Alexandra Gorelik; Benjamin Thomson
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

3.  Magnitude of non-operative surgical emergency admissions; service implications for surgical and radiological practice.

Authors:  R M Heaney; I Reynolds; R S Ryan; I Khan; W Khan; R Waldron; K Barry
Journal:  Ir J Med Sci       Date:  2016-09-08       Impact factor: 1.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.